Investors
2024 full year and fourth quarter announcement
We announced our full year and fourth quarter 2024 results on Wednesday 5 February. Access our full year and fourth quarter results and latest Annual Report below.
We’re confident in our future
With our strong momentum and improving outlook for sustained growth through the decade, we're confident in our ability to deliver human health impact at scale, worldwide.
Speeches and presentations
GSK dividend
GSK share price
Share price tool
Detailed information on GSK's share price, including an interactive chart
Behind the science
Read our latest articles
Three facts scientists have learned about RSV – and why sharing them could help protect those most at risk
‘Long-acting therapies are no longer the future of HIV treatment – they are the now’
Is it COVID-19, flu, or RSV? The symptoms to look out for – and how to tell the difference
‘The whooping cough outbreak is a stark reminder of just how important lifelong vaccination is’
‘It was not something I was warned about’: Preventing permanent organ damage in patients with lupus
78% of gynaecologic cancer patients experience challenges accessing the treatment they need, new survey shows
'Prevention is the best medicine to stop disease before it starts'
‘Teenagers may feel invincible – but we’re at risk’: What you need to know about meningitis as post-COVID cases continue to rebound
‘We never think AMR is going to happen to us’: The human cost of antimicrobial resistance – and how to prevent it
‘Putting patients first means caring about the air they breathe – and reducing the impact of respiratory care on the environment’
